Literature DB >> 17316541

Identification of inhibitors using a cell-based assay for monitoring Golgi-resident protease activity.

Julia M Coppola1, Christin A Hamilton, Mahaveer S Bhojani, Martha J Larsen, Brian D Ross, Alnawaz Rehemtulla.   

Abstract

Noninvasive real-time quantification of cellular protease activity allows monitoring of enzymatic activity and identification of activity modulators within the protease's natural milieu. We developed a protease activity assay based on differential localization of a recombinant reporter consisting of a Golgi retention signal and a protease cleavage sequence fused to alkaline phosphatase (AP). When expressed in mammalian cells, this protein localizes to Golgi bodies and, on protease-mediated cleavage, AP translocates to the extracellular medium where its activity is measured. We used this system to monitor the Golgi-associated protease furin, a pluripotent enzyme with a key role in tumorigenesis, viral propagation of avian influenza, ebola, and HIV as well as in activation of anthrax, pseudomonas, and diphtheria toxins. This technology was adapted for high-throughput screening of 39,000-compound small molecule libraries, leading to identification of furin inhibitors. Furthermore, this strategy was used to identify inhibitors of another Golgi protease, the beta-site amyloid precursor protein (APP)-cleaving enzyme (BACE). BACE cleavage of the APP leads to formation of the Abeta peptide, a key event that leads to Alzheimer's disease. In conclusion, we describe a customizable noninvasive technology for real-time assessment of Golgi protease activity used to identify inhibitors of furin and BACE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316541      PMCID: PMC1995463          DOI: 10.1016/j.ab.2007.01.013

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  52 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

Review 2.  Emerging Alzheimer's disease therapies: inhibition of beta-secretase.

Authors:  Martin Citron
Journal:  Neurobiol Aging       Date:  2002 Nov-Dec       Impact factor: 4.673

3.  A role for PACE4 in the proteolytic activation of anthrax toxin protective antigen.

Authors:  V M Gordon; A Rehemtulla; S H Leppla
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

Review 4.  The Alzheimer family of diseases: many etiologies, one pathogenesis?

Authors:  J Hardy
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 5.  Anti-inflammatory drugs in the fight against Alzheimer's disease.

Authors:  P L McGeer; E G McGeer
Journal:  Ann N Y Acad Sci       Date:  1996-01-17       Impact factor: 5.691

6.  cDNA structure, tissue distribution, and chromosomal localization of rat PC7, a novel mammalian proprotein convertase closest to yeast kexin-like proteinases.

Authors:  N G Seidah; J Hamelin; M Mamarbachi; W Dong; H Tardos; M Mbikay; M Chretien; R Day
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

Review 7.  Maturation of HIV envelope glycoprotein precursors by cellular endoproteases.

Authors:  M Moulard; E Decroly
Journal:  Biochim Biophys Acta       Date:  2000-11-10

8.  Furin inhibition by compounds of copper and zinc.

Authors:  Paul Podsiadlo; Tomoko Komiyama; Robert S Fuller; Ofer Blum
Journal:  J Biol Chem       Date:  2004-05-12       Impact factor: 5.157

9.  Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediated by the human endoprotease furin.

Authors:  M Vey; W Schäfer; B Reis; R Ohuchi; W Britt; W Garten; H D Klenk; K Radsak
Journal:  Virology       Date:  1995-01-10       Impact factor: 3.616

Review 10.  The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions.

Authors:  N G Seidah; M Chrétien; R Day
Journal:  Biochimie       Date:  1994       Impact factor: 4.079

View more
  15 in total

1.  Molecular Validation of PACE4 as a Target in Prostate Cancer.

Authors:  François D'Anjou; Sophie Routhier; Jean-Pierre Perreault; Alain Latil; David Bonnel; Isabelle Fournier; Michel Salzet; Robert Day
Journal:  Transl Oncol       Date:  2011-06-01       Impact factor: 4.243

Review 2.  Applications of molecular imaging.

Authors:  Craig J Galbán; Stefanie Galbán; Marcian E Van Dort; Gary D Luker; Mahaveer S Bhojani; Alnawaz Rehemtulla; Brian D Ross
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

3.  On the cutting edge of proprotein convertase pharmacology: from molecular concepts to clinical applications.

Authors:  Frédéric Couture; François D'Anjou; Robert Day
Journal:  Biomol Concepts       Date:  2011-10-01

4.  Identification of potent and compartment-selective small molecule furin inhibitors using cell-based assays.

Authors:  Bruno Ramos-Molina; Adam N Lick; Elias H Blanco; J Alejandro Posada-Salgado; Karina Martinez-Mayorga; Alan T Johnson; Guan-Sheng Jiao; Iris Lindberg
Journal:  Biochem Pharmacol       Date:  2015-05-21       Impact factor: 5.858

5.  MScreen: an integrated compound management and high-throughput screening data storage and analysis system.

Authors:  Renju T Jacob; Martha J Larsen; Scott D Larsen; Paul D Kirchhoff; David H Sherman; Richard R Neubig
Journal:  J Biomol Screen       Date:  2012-06-15

6.  Synthetic small-molecule prohormone convertase 2 inhibitors.

Authors:  Dorota Kowalska; Jin Liu; Jon R Appel; Akihiko Ozawa; Adel Nefzi; Robert B Mackin; Richard A Houghten; Iris Lindberg
Journal:  Mol Pharmacol       Date:  2008-12-12       Impact factor: 4.436

7.  Imaging proprotein convertase activities and their regulation in the implanting mouse blastocyst.

Authors:  Daniel Mesnard; Daniel B Constam
Journal:  J Cell Biol       Date:  2010-09-27       Impact factor: 10.539

8.  Noninvasive imaging of apoptosis and its application in cancer therapeutics.

Authors:  Julia M Coppola; Brian D Ross; Alnawaz Rehemtulla
Journal:  Clin Cancer Res       Date:  2008-04-15       Impact factor: 12.531

9.  Generation and characterization of non-competitive furin-inhibiting nanobodies.

Authors:  Jingjing Zhu; Jeroen Declercq; Bart Roucourt; Gholamreza H Ghassabeh; Sandra Meulemans; Jörg Kinne; Guido David; Alphons J M Vermorken; Wim J M Van de Ven; Iris Lindberg; Serge Muyldermans; John W M Creemers
Journal:  Biochem J       Date:  2012-11-15       Impact factor: 3.857

10.  A novel enediynyl peptide inhibitor of furin that blocks processing of proPDGF-A, B and proVEGF-C.

Authors:  Ajoy Basak; Abdel-Majid Khatib; Dayani Mohottalage; Sarmistha Basak; Maria Kolajova; Subhendu Sekhar Bag; Amit Basak
Journal:  PLoS One       Date:  2009-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.